{"transactions":[{"id":1110478,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":78483,"kind":"person","name":"Hutson Nancy J","position":1,"cik":"0001379222","reported_name":"Hutson Nancy J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Automatic Stock Option Grant","published_at":"2025-06-16T20:20:08.000Z","date":"2025-06-12","kind":"grant","planned":false,"acquired":true,"shares":27181,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Automatic non-employee director grant of stock options pursuant to the Director Compensation Policy."}],"balance_after":27181,"derivative":{"exercise_price":10.4,"exercise_date":"2026-06-12","expiration_date":"2035-06-12","underlying":"Common Stock","underlying_shares":27181},"source":{"system":"sec-edgar","filing":"0001171843-25-003914","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882796/000117184325003914/ownership.xml","form_type":"4"}},{"id":1110477,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":78483,"kind":"person","name":"Hutson Nancy J","position":1,"cik":"0001379222","reported_name":"Hutson Nancy J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-16T20:20:08.000Z","date":"2025-06-12","kind":"grant","planned":false,"acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Automatic non-employee director grant of Restricted Stock Units pursuant to the BioCryst Pharmaceuticals, Inc. Non-Employee Director Compensation Policy, as amended (the \"Director Compensation Policy\"), which will vest on the first anniversary of the date of grant."}],"balance_after":99138,"source":{"system":"sec-edgar","filing":"0001171843-25-003914","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882796/000117184325003914/ownership.xml","form_type":"4"}},{"id":1331453,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":78483,"kind":"person","name":"Hutson Nancy J","position":1,"cik":"0001379222","reported_name":"Hutson Nancy J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-12-16T21:35:50.000Z","date":"2024-12-13","kind":"sale","planned":true,"acquired":false,"shares":7000,"price":7.54,"value":52780.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were sold pursuant to a plan adopted by the Reporting Person on June 18, 2024 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended, for the sole purpose of generating sufficient proceeds to cover the tax liability incurred in connection with the vesting of 16,745 restricted stock units. The sale occurred automatically and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price in column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $7.510 to $7.565. The Reporting Person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote."}],"balance_after":86638,"source":{"system":"sec-edgar","filing":"0001127602-24-029494","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882796/000112760224029494/form4.xml","form_type":"4"}},{"id":1471799,"issuer":{"id":82875,"kind":"organization","name":"Clearside Biomedical, Inc.","symbol":"CLSD"},"owners":[{"id":78483,"kind":"person","name":"Hutson Nancy J","position":1,"cik":"0001379222","reported_name":"Hutson Nancy J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-21T16:15:18.000Z","date":"2024-06-20","kind":"grant","planned":false,"acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest in full on the earlier of the Issuer's next annual meeting of stockholders or June 20, 2025, subject to the Reporting Person's continuous service as of such vesting date."}],"balance_after":45000,"derivative":{"exercise_price":1.15,"expiration_date":"2034-06-19","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001415889-24-017825","document":"form4-06212024_040614.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1379222/000141588924017825/form4-06212024_040614.xml","form_type":"4"}},{"id":1479829,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":78483,"kind":"person","name":"Hutson Nancy J","position":1,"cik":"0001379222","reported_name":"Hutson Nancy J","relationship":{"director":true}}],"security":"Automatic Stock Option Grant","published_at":"2024-06-14T20:27:05.000Z","date":"2024-06-12","kind":"grant","planned":false,"acquired":true,"shares":49933,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Automatic non-employee director grant of stock options pursuant to the Director Compensation Policy."}],"balance_after":49933,"derivative":{"exercise_price":6.3,"exercise_date":"2025-06-12","expiration_date":"2034-06-12","underlying":"Common Stock","underlying_shares":49933},"source":{"system":"sec-edgar","filing":"0001127602-24-018720","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882796/000112760224018720/form4.xml","form_type":"4"}},{"id":1479828,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":78483,"kind":"person","name":"Hutson Nancy J","position":1,"cik":"0001379222","reported_name":"Hutson Nancy J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-06-14T20:27:05.000Z","date":"2024-06-12","kind":"grant","planned":false,"acquired":true,"shares":6820,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Automatic non-employee director grant of Restricted Stock Units pursuant to the BioCryst Pharmaceuticals, Inc. Non-Employee Director Compensation Policy, as amended (the \"Director Compensation Policy\"), which will vest on the first anniversary of the date of grant."}],"balance_after":93638,"source":{"system":"sec-edgar","filing":"0001127602-24-018720","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882796/000112760224018720/form4.xml","form_type":"4"}},{"id":1506175,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":78483,"kind":"person","name":"Hutson Nancy J","position":1,"cik":"0001379222","reported_name":"Hutson Nancy J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-05-22T11:24:51.000Z","date":"2024-05-20","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":6.38,"value":31900.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price in column 4 is a weighted average price.  These shares were purchased in multiple transactions ranging from $6.375 to $6.38. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares purchased at each price within the range set forth in this footnote."}],"balance_after":86818,"source":{"system":"sec-edgar","filing":"0001127602-24-016190","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882796/000112760224016190/form4.xml","form_type":"4"}},{"id":1764999,"issuer":{"id":82875,"kind":"organization","name":"Clearside Biomedical, Inc.","symbol":"CLSD"},"owners":[{"id":78483,"kind":"person","name":"Hutson Nancy J","position":1,"cik":"0001379222","reported_name":"Hutson Nancy J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-10-04T17:06:34.000Z","date":"2023-10-03","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":0.86,"value":8600.0,"ownership":{"direct":true},"balance_after":93000,"source":{"system":"sec-edgar","filing":"0001209191-23-052027","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1379222/000120919123052027/doc4.xml","form_type":"4"}},{"id":1844940,"issuer":{"id":82875,"kind":"organization","name":"Clearside Biomedical, Inc.","symbol":"CLSD"},"owners":[{"id":78483,"kind":"person","name":"Hutson Nancy J","position":1,"cik":"0001379222","reported_name":"Hutson Nancy J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-23T16:38:03.000Z","date":"2023-06-22","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest in full on the earlier of the Issuer's next annual meeting of stockholders or June 22, 2024, subject to the Reporting Person's continuous service as of such vesting date."}],"balance_after":30000,"derivative":{"exercise_price":1.31,"expiration_date":"2033-06-21","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001209191-23-039419","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1379222/000120919123039419/doc4.xml","form_type":"4"}},{"id":1855059,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":78483,"kind":"person","name":"Hutson Nancy J","position":1,"cik":"0001379222","reported_name":"Hutson Nancy J","relationship":{"director":true}}],"security":"Automatic Stock Option Grant","published_at":"2023-06-15T20:33:37.000Z","date":"2023-06-13","kind":"grant","planned":false,"acquired":true,"shares":39072,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Automatic non-employee director grant of stock options pursuant to the Director Compensation Policy."}],"balance_after":39072,"derivative":{"exercise_price":8.18,"exercise_date":"2024-06-13","expiration_date":"2033-06-13","underlying":"Common Stock","underlying_shares":39072},"source":{"system":"sec-edgar","filing":"0001127602-23-018775","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882796/000112760223018775/form4.xml","form_type":"4"}},{"id":1855058,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":78483,"kind":"person","name":"Hutson Nancy J","position":1,"cik":"0001379222","reported_name":"Hutson Nancy J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-06-15T20:33:37.000Z","date":"2023-06-14","kind":"sale","planned":false,"acquired":false,"shares":12866,"price":8.04,"value":103442.64,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price in column 4 is a weighted average price.  These shares were purchased in multiple transactions ranging from $7.89 to $8.12.  The reporting person will provide to the issuer, or any security holder of the issuer, or the SEC staff upon request, full information regarding the number of shares purchased at each price within the range set forth in the footnote."}],"balance_after":81818,"source":{"system":"sec-edgar","filing":"0001127602-23-018775","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882796/000112760223018775/form4.xml","form_type":"4"}},{"id":1855057,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":78483,"kind":"person","name":"Hutson Nancy J","position":1,"cik":"0001379222","reported_name":"Hutson Nancy J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-06-15T20:33:37.000Z","date":"2023-06-13","kind":"grant","planned":false,"acquired":true,"shares":16745,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Automatic non-employee director grant of Restricted Stock Units pursuant to the BioCryst Pharmaceuticals, Inc. Non-Employee Director Compensation Policy (the \"Director Compensation Policy\"), which will vest on the first anniversary of the date of grant."}],"balance_after":94684,"source":{"system":"sec-edgar","filing":"0001127602-23-018775","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882796/000112760223018775/form4.xml","form_type":"4"}},{"id":1885186,"issuer":{"id":113305,"kind":"organization","name":"PhaseBio Pharmaceuticals Inc","symbol":"PHAS"},"owners":[{"id":78483,"kind":"person","name":"Hutson Nancy J","position":1,"cik":"0001379222","reported_name":"Hutson Nancy J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-05-19T16:15:57.000Z","date":"2023-05-19","kind":"exercise","planned":false,"acquired":false,"shares":3750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of PhaseBio Pharmaceuticals, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vested and were delivered to the Reporting Person on the one-year anniversary of the grant date, subject to the Reporting Person's continuous service through such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vested and were delivered to the Reporting Person on the one-year anniversary of the grant date, subject to the Reporting Person's continuous service through such date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":3750},"source":{"system":"sec-edgar","filing":"0001169245-23-000027","document":"wf-form4_168452733692556.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1169245/000116924523000027/wf-form4_168452733692556.xml","form_type":"4"}},{"id":1885185,"issuer":{"id":113305,"kind":"organization","name":"PhaseBio Pharmaceuticals Inc","symbol":"PHAS"},"owners":[{"id":78483,"kind":"person","name":"Hutson Nancy J","position":1,"cik":"0001379222","reported_name":"Hutson Nancy J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-19T16:15:57.000Z","date":"2023-05-19","kind":"exercise","planned":false,"acquired":true,"shares":3750,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of PhaseBio Pharmaceuticals, Inc. common stock."}],"balance_after":37510,"source":{"system":"sec-edgar","filing":"0001169245-23-000027","document":"wf-form4_168452733692556.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1169245/000116924523000027/wf-form4_168452733692556.xml","form_type":"4"}},{"id":2108363,"issuer":{"id":82875,"kind":"organization","name":"Clearside Biomedical, Inc.","symbol":"CLSD"},"owners":[{"id":78483,"kind":"person","name":"Hutson Nancy J","position":1,"cik":"0001379222","reported_name":"Hutson Nancy J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-11-21T08:12:21.000Z","date":"2022-11-17","kind":"purchase","acquired":true,"shares":30000,"price":1.33,"value":39900.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.31 to $1.35, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":83000,"source":{"system":"sec-edgar","filing":"0001209191-22-058025","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1379222/000120919122058025/doc4.xml","form_type":"4"}},{"id":2221838,"issuer":{"id":82875,"kind":"organization","name":"Clearside Biomedical, Inc.","symbol":"CLSD"},"owners":[{"id":78483,"kind":"person","name":"Hutson Nancy J","position":1,"cik":"0001379222","reported_name":"Hutson Nancy J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-24T16:25:46.000Z","date":"2022-06-22","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest in full on the earlier of the Issuer's next annual meeting of stockholders or June 22, 2023."}],"balance_after":30000,"derivative":{"exercise_price":1.62,"expiration_date":"2032-06-21","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001209191-22-039233","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1379222/000120919122039233/doc4.xml","form_type":"4"}},{"id":2238285,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":78483,"kind":"person","name":"Hutson Nancy J","position":1,"cik":"0001379222","reported_name":"Hutson Nancy J","relationship":{"director":true}}],"security":"Automatic Stock Option Grant","published_at":"2022-06-09T20:48:26.000Z","date":"2022-06-07","kind":"grant","acquired":true,"shares":30022,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Automatic non-employee director grant of stock options pursuant to the Director Compensation Policy."}],"balance_after":30022,"derivative":{"exercise_price":10.79,"exercise_date":"2023-06-07","expiration_date":"2032-06-07","underlying":"Common Stock","underlying_shares":30022},"source":{"system":"sec-edgar","filing":"0001127602-22-017163","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882796/000112760222017163/form4.xml","form_type":"4"}},{"id":2238284,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":78483,"kind":"person","name":"Hutson Nancy J","position":1,"cik":"0001379222","reported_name":"Hutson Nancy J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-06-09T20:48:26.000Z","date":"2022-06-07","kind":"grant","acquired":true,"shares":12866,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Automatic non-employee director grant of Restricted Stock Units pursuant to the BioCryst Pharmaceuticals, Inc. Non-Employee Director Compensation Policy (the \"Director Compensation Policy\"), which will vest on the first anniversary of the date of grant."}],"balance_after":77939,"source":{"system":"sec-edgar","filing":"0001127602-22-017163","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882796/000112760222017163/form4.xml","form_type":"4"}},{"id":2262232,"issuer":{"id":113305,"kind":"organization","name":"PhaseBio Pharmaceuticals Inc","symbol":"PHAS"},"owners":[{"id":78483,"kind":"person","name":"Hutson Nancy J","position":1,"cik":"0001379222","reported_name":"Hutson Nancy J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-20T16:47:13.000Z","date":"2021-08-18","kind":"purchase","acquired":true,"shares":3000,"price":3.08,"value":9240.0,"ownership":{"direct":false,"nature":"Held in an individual retirement account for the benefit of the Reporting Person"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.07 to $3.08, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4."}],"balance_after":4000,"source":{"system":"sec-edgar","filing":"0001169245-22-000067","document":"wf-form4a_165307960124153.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1169245/000116924522000067/wf-form4a_165307960124153.xml","form_type":"4/A","original_submission_date":"2021-08-19"}},{"id":2262226,"issuer":{"id":113305,"kind":"organization","name":"PhaseBio Pharmaceuticals Inc","symbol":"PHAS"},"owners":[{"id":78483,"kind":"person","name":"Hutson Nancy J","position":1,"cik":"0001379222","reported_name":"Hutson Nancy J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-05-20T16:45:41.000Z","date":"2022-05-19","kind":"grant","acquired":true,"shares":3750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of PhaseBio Pharmaceuticals, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs shall vest and be delivered to the Reporting Person on the earlier of the one-year anniversary of the grant date or the 2023 annual stockholder meeting, subject to the Reporting Person's continuous service through such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs shall vest and be delivered to the Reporting Person on the earlier of the one-year anniversary of the grant date or the 2023 annual stockholder meeting, subject to the Reporting Person's continuous service through such date."}],"balance_after":3750,"derivative":{"underlying":"Common Stock","underlying_shares":3750},"source":{"system":"sec-edgar","filing":"0001169245-22-000064","document":"wf-form4_165307952529586.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1169245/000116924522000064/wf-form4_165307952529586.xml","form_type":"4"}},{"id":2262225,"issuer":{"id":113305,"kind":"organization","name":"PhaseBio Pharmaceuticals Inc","symbol":"PHAS"},"owners":[{"id":78483,"kind":"person","name":"Hutson Nancy J","position":1,"cik":"0001379222","reported_name":"Hutson Nancy J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-employee Director Stock Option (right to buy)","published_at":"2022-05-20T16:45:41.000Z","date":"2022-05-19","kind":"grant","acquired":true,"shares":17500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest on the earlier of the one-year anniversary of the grant date or the 2023 annual stockholder meeting, subject to the Reporting Person's continuous service through such date."}],"balance_after":17500,"derivative":{"exercise_price":0.8419,"expiration_date":"2032-05-18","underlying":"Common Stock","underlying_shares":17500},"source":{"system":"sec-edgar","filing":"0001169245-22-000064","document":"wf-form4_165307952529586.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1169245/000116924522000064/wf-form4_165307952529586.xml","form_type":"4"}},{"id":2521656,"issuer":{"id":113305,"kind":"organization","name":"PhaseBio Pharmaceuticals Inc","symbol":"PHAS"},"owners":[{"id":78483,"kind":"person","name":"Hutson Nancy J","position":1,"cik":"0001379222","reported_name":"Hutson Nancy J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-employee Director Stock Option (right to buy)","published_at":"2021-11-08T18:26:09.000Z","date":"2021-11-08","kind":"exercise","acquired":false,"shares":7400,"price":3.15,"value":23310.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option shall vest in equal monthly installments over 36 months from October 17, 2018, subject to the reporting person's continued service through each such date."}],"balance_after":0,"derivative":{"exercise_price":3.15,"expiration_date":"2029-02-27","underlying":"Common Stock","underlying_shares":7400},"source":{"system":"sec-edgar","filing":"0001169245-21-000106","document":"wf-form4_163641394792074.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1169245/000116924521000106/wf-form4_163641394792074.xml","form_type":"4"}},{"id":2521655,"issuer":{"id":113305,"kind":"organization","name":"PhaseBio Pharmaceuticals Inc","symbol":"PHAS"},"owners":[{"id":78483,"kind":"person","name":"Hutson Nancy J","position":1,"cik":"0001379222","reported_name":"Hutson Nancy J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-employee Director Stock Option (right to buy)","published_at":"2021-11-08T18:26:09.000Z","date":"2021-11-05","kind":"exercise","acquired":false,"shares":1500,"price":3.15,"value":4725.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option shall vest in equal monthly installments over 36 months from October 17, 2018, subject to the reporting person's continued service through each such date."}],"balance_after":7400,"derivative":{"exercise_price":3.15,"expiration_date":"2029-02-27","underlying":"Common Stock","underlying_shares":1500},"source":{"system":"sec-edgar","filing":"0001169245-21-000106","document":"wf-form4_163641394792074.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1169245/000116924521000106/wf-form4_163641394792074.xml","form_type":"4"}},{"id":2521654,"issuer":{"id":113305,"kind":"organization","name":"PhaseBio Pharmaceuticals Inc","symbol":"PHAS"},"owners":[{"id":78483,"kind":"person","name":"Hutson Nancy J","position":1,"cik":"0001379222","reported_name":"Hutson Nancy J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-employee Director Stock Option (right to buy)","published_at":"2021-11-08T18:26:09.000Z","date":"2021-11-05","kind":"exercise","acquired":false,"shares":24860,"price":2.26,"value":56183.6,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option shall vest with respect to 25% of the shares on February 21, 2019, and shall vest in 36 additional monthly installments thereafter, subject to the reporting person's continued service through each such date."}],"balance_after":2256,"derivative":{"exercise_price":2.26,"expiration_date":"2028-05-03","underlying":"Common Stock","underlying_shares":24860},"source":{"system":"sec-edgar","filing":"0001169245-21-000106","document":"wf-form4_163641394792074.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1169245/000116924521000106/wf-form4_163641394792074.xml","form_type":"4"}},{"id":2521653,"issuer":{"id":113305,"kind":"organization","name":"PhaseBio Pharmaceuticals Inc","symbol":"PHAS"},"owners":[{"id":78483,"kind":"person","name":"Hutson Nancy J","position":1,"cik":"0001379222","reported_name":"Hutson Nancy J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-08T18:26:09.000Z","date":"2021-11-08","kind":"exercise","acquired":true,"shares":7400,"price":3.15,"value":23310.0,"ownership":{"direct":true},"balance_after":33760,"source":{"system":"sec-edgar","filing":"0001169245-21-000106","document":"wf-form4_163641394792074.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1169245/000116924521000106/wf-form4_163641394792074.xml","form_type":"4"}},{"id":2521652,"issuer":{"id":113305,"kind":"organization","name":"PhaseBio Pharmaceuticals Inc","symbol":"PHAS"},"owners":[{"id":78483,"kind":"person","name":"Hutson Nancy J","position":1,"cik":"0001379222","reported_name":"Hutson Nancy J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-08T18:26:09.000Z","date":"2021-11-05","kind":"exercise","acquired":true,"shares":1500,"price":3.15,"value":4725.0,"ownership":{"direct":true},"balance_after":26360,"source":{"system":"sec-edgar","filing":"0001169245-21-000106","document":"wf-form4_163641394792074.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1169245/000116924521000106/wf-form4_163641394792074.xml","form_type":"4"}},{"id":2521651,"issuer":{"id":113305,"kind":"organization","name":"PhaseBio Pharmaceuticals Inc","symbol":"PHAS"},"owners":[{"id":78483,"kind":"person","name":"Hutson Nancy J","position":1,"cik":"0001379222","reported_name":"Hutson Nancy J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-08T18:26:09.000Z","date":"2021-11-05","kind":"exercise","acquired":true,"shares":24860,"price":2.26,"value":56183.6,"ownership":{"direct":true},"balance_after":24860,"source":{"system":"sec-edgar","filing":"0001169245-21-000106","document":"wf-form4_163641394792074.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1169245/000116924521000106/wf-form4_163641394792074.xml","form_type":"4"}},{"id":2528343,"issuer":{"id":82875,"kind":"organization","name":"Clearside Biomedical, Inc.","symbol":"CLSD"},"owners":[{"id":78483,"kind":"person","name":"Hutson Nancy J","position":1,"cik":"0001379222","reported_name":"Hutson Nancy J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-11-02T16:40:17.000Z","date":"2021-10-29","kind":"exercise","acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option will vest and become exercisable in 36 equal monthly installments beginning on May 21, 2020, subject to the Reporting Person's continuous service as of such vesting dates."}],"balance_after":15000,"derivative":{"exercise_price":2.09,"expiration_date":"2030-04-20","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-21-062427","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1379222/000120919121062427/doc4.xml","form_type":"4"}},{"id":2528342,"issuer":{"id":82875,"kind":"organization","name":"Clearside Biomedical, Inc.","symbol":"CLSD"},"owners":[{"id":78483,"kind":"person","name":"Hutson Nancy J","position":1,"cik":"0001379222","reported_name":"Hutson Nancy J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-11-02T16:40:17.000Z","date":"2021-10-29","kind":"exercise","acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option were fully vested as of June 18, 2021."}],"balance_after":0,"derivative":{"exercise_price":2,"expiration_date":"2030-06-17","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-21-062427","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1379222/000120919121062427/doc4.xml","form_type":"4"}},{"id":2528341,"issuer":{"id":82875,"kind":"organization","name":"Clearside Biomedical, Inc.","symbol":"CLSD"},"owners":[{"id":78483,"kind":"person","name":"Hutson Nancy J","position":1,"cik":"0001379222","reported_name":"Hutson Nancy J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-02T16:40:17.000Z","date":"2021-10-29","kind":"exercise","acquired":true,"shares":15000,"price":2.09,"value":31350.0,"ownership":{"direct":true},"balance_after":53000,"source":{"system":"sec-edgar","filing":"0001209191-21-062427","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1379222/000120919121062427/doc4.xml","form_type":"4"}},{"id":2528340,"issuer":{"id":82875,"kind":"organization","name":"Clearside Biomedical, Inc.","symbol":"CLSD"},"owners":[{"id":78483,"kind":"person","name":"Hutson Nancy J","position":1,"cik":"0001379222","reported_name":"Hutson Nancy J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-02T16:40:17.000Z","date":"2021-10-29","kind":"exercise","acquired":true,"shares":25000,"price":2,"value":50000.0,"ownership":{"direct":true},"balance_after":38000,"source":{"system":"sec-edgar","filing":"0001209191-21-062427","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1379222/000120919121062427/doc4.xml","form_type":"4"}},{"id":2539961,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":78483,"kind":"person","name":"Hutson Nancy J","position":1,"cik":"0001379222","reported_name":"Hutson Nancy J","relationship":{"director":true}}],"security":"Automatic Stock Option Grant","published_at":"2021-10-19T20:21:49.000Z","date":"2021-10-15","kind":"exercise","acquired":false,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2021."}],"balance_after":0,"derivative":{"exercise_price":3.22,"exercise_date":"2016-06-23","expiration_date":"2026-05-23","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001127602-21-027342","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/882796/000112760221027342/form4.xml","form_type":"4"}},{"id":2539960,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":78483,"kind":"person","name":"Hutson Nancy J","position":1,"cik":"0001379222","reported_name":"Hutson Nancy J","relationship":{"director":true}}],"security":"Automatic Stock Option Grant","published_at":"2021-10-19T20:21:49.000Z","date":"2021-10-15","kind":"exercise","acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2021."}],"balance_after":0,"derivative":{"exercise_price":1.71,"exercise_date":"2013-06-30","expiration_date":"2023-05-31","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001127602-21-027342","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/882796/000112760221027342/form4.xml","form_type":"4"}},{"id":2539959,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":78483,"kind":"person","name":"Hutson Nancy J","position":1,"cik":"0001379222","reported_name":"Hutson Nancy J","relationship":{"director":true}}],"security":"Automatic Stock Option Grant","published_at":"2021-10-19T20:21:49.000Z","date":"2021-10-15","kind":"exercise","acquired":false,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2021."}],"balance_after":0,"derivative":{"exercise_price":5.13,"exercise_date":"2017-06-24","expiration_date":"2027-05-24","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001127602-21-027342","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/882796/000112760221027342/form4.xml","form_type":"4"}},{"id":2539958,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":78483,"kind":"person","name":"Hutson Nancy J","position":1,"cik":"0001379222","reported_name":"Hutson Nancy J","relationship":{"director":true}}],"security":"Automatic Stock Option Grant","published_at":"2021-10-19T20:21:49.000Z","date":"2021-10-15","kind":"exercise","acquired":false,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2021."}],"balance_after":0,"derivative":{"exercise_price":2.91,"exercise_date":"2020-05-29","expiration_date":"2029-05-29","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001127602-21-027342","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/882796/000112760221027342/form4.xml","form_type":"4"}},{"id":2539957,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":78483,"kind":"person","name":"Hutson Nancy J","position":1,"cik":"0001379222","reported_name":"Hutson Nancy J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-10-19T20:21:49.000Z","date":"2021-10-15","kind":"sale","acquired":false,"shares":105000,"price":15.4,"value":1617000.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price in column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $15.13 to $15.51. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote."}],"balance_after":65073,"source":{"system":"sec-edgar","filing":"0001127602-21-027342","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/882796/000112760221027342/form4.xml","form_type":"4"}},{"id":2539956,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":78483,"kind":"person","name":"Hutson Nancy J","position":1,"cik":"0001379222","reported_name":"Hutson Nancy J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-10-19T20:21:49.000Z","date":"2021-10-15","kind":"exercise","acquired":true,"shares":30000,"price":3.22,"value":96600.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2021."}],"balance_after":170073,"source":{"system":"sec-edgar","filing":"0001127602-21-027342","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/882796/000112760221027342/form4.xml","form_type":"4"}},{"id":2539955,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":78483,"kind":"person","name":"Hutson Nancy J","position":1,"cik":"0001379222","reported_name":"Hutson Nancy J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-10-19T20:21:49.000Z","date":"2021-10-15","kind":"exercise","acquired":true,"shares":15000,"price":1.71,"value":25650.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2021."}],"balance_after":140073,"source":{"system":"sec-edgar","filing":"0001127602-21-027342","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882796/000112760221027342/form4.xml","form_type":"4"}},{"id":2539954,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":78483,"kind":"person","name":"Hutson Nancy J","position":1,"cik":"0001379222","reported_name":"Hutson Nancy J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-10-19T20:21:49.000Z","date":"2021-10-15","kind":"exercise","acquired":true,"shares":30000,"price":5.13,"value":153900.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2021."}],"balance_after":125073,"source":{"system":"sec-edgar","filing":"0001127602-21-027342","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882796/000112760221027342/form4.xml","form_type":"4"}},{"id":2539953,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":78483,"kind":"person","name":"Hutson Nancy J","position":1,"cik":"0001379222","reported_name":"Hutson Nancy J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-10-19T20:21:49.000Z","date":"2021-10-15","kind":"exercise","acquired":true,"shares":30000,"price":2.91,"value":87300.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2021."}],"balance_after":95073,"source":{"system":"sec-edgar","filing":"0001127602-21-027342","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882796/000112760221027342/form4.xml","form_type":"4"}},{"id":2596395,"issuer":{"id":113305,"kind":"organization","name":"PhaseBio Pharmaceuticals Inc","symbol":"PHAS"},"owners":[{"id":78483,"kind":"person","name":"Hutson Nancy J","position":1,"cik":"0001379222","reported_name":"Hutson Nancy J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-08-19T16:24:51.000Z","date":"2021-08-18","kind":"purchase","acquired":true,"shares":3000,"price":3.08,"value":9240.0,"ownership":{"direct":false,"nature":"Held in an individual retirement account for the benefit of the reporting person"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.07 to $3.08, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4."}],"balance_after":4000,"source":{"system":"sec-edgar","filing":"0001169245-21-000083","document":"wf-form4_162940466260409.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1169245/000116924521000083/wf-form4_162940466260409.xml","form_type":"4"}},{"id":2599490,"issuer":{"id":82875,"kind":"organization","name":"Clearside Biomedical, Inc.","symbol":"CLSD"},"owners":[{"id":78483,"kind":"person","name":"Hutson Nancy J","position":1,"cik":"0001379222","reported_name":"Hutson Nancy J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-08-17T16:39:43.000Z","date":"2021-08-16","kind":"purchase","acquired":true,"shares":3000,"price":5.68,"value":17040.0,"ownership":{"direct":true},"balance_after":13000,"source":{"system":"sec-edgar","filing":"0001209191-21-051883","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1379222/000120919121051883/doc4.xml","form_type":"4"}},{"id":2667810,"issuer":{"id":124463,"kind":"organization","name":"Endo International plc","symbol":"ENDP"},"owners":[{"id":78483,"kind":"person","name":"Hutson Nancy J","position":1,"cik":"0001379222","reported_name":"Hutson Nancy J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2021-06-15T16:06:23.000Z","date":"2021-06-11","kind":"tax_withholding","acquired":false,"shares":23003,"price":6.26,"value":143998.78,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These shares represent ordinary shares withheld by Endo International plc to satisfy Dr. Hutson's tax withholding obligations on shares acquired on June 11, 2021."}],"balance_after":116140,"source":{"system":"sec-edgar","filing":"0001593034-21-000079","document":"wf-form4_162378753940214.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1379222/000159303421000079/wf-form4_162378753940214.xml","form_type":"4"}},{"id":2667809,"issuer":{"id":124463,"kind":"organization","name":"Endo International plc","symbol":"ENDP"},"owners":[{"id":78483,"kind":"person","name":"Hutson Nancy J","position":1,"cik":"0001379222","reported_name":"Hutson Nancy J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2021-06-15T16:06:23.000Z","date":"2021-06-11","kind":"grant","acquired":true,"shares":47924,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These ordinary shares were granted to Dr. Hutson on June 11, 2021 in consideration of her services on Endo International plc's Board of Directors."}],"balance_after":139143,"source":{"system":"sec-edgar","filing":"0001593034-21-000079","document":"wf-form4_162378753940214.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1379222/000159303421000079/wf-form4_162378753940214.xml","form_type":"4"}},{"id":2670896,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":78483,"kind":"person","name":"Hutson Nancy J","position":1,"cik":"0001379222","reported_name":"Hutson Nancy J","relationship":{"director":true}}],"security":"Automatic Stock Option Grant","published_at":"2021-06-14T20:29:33.000Z","date":"2021-06-10","kind":"exercise","acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 10, 2021."}],"balance_after":0,"derivative":{"exercise_price":3.32,"exercise_date":"2012-06-23","expiration_date":"2022-05-23","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001127602-21-019792","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/882796/000112760221019792/form4.xml","form_type":"4"}},{"id":2670895,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":78483,"kind":"person","name":"Hutson Nancy J","position":1,"cik":"0001379222","reported_name":"Hutson Nancy J","relationship":{"director":true}}],"security":"Non-Qualified Stock Option","published_at":"2021-06-14T20:29:33.000Z","date":"2021-06-10","kind":"exercise","acquired":false,"shares":8333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 10, 2021."}],"balance_after":0,"derivative":{"exercise_price":2.85,"exercise_date":"2012-02-20","expiration_date":"2022-01-20","underlying":"Common Stock","underlying_shares":8333},"source":{"system":"sec-edgar","filing":"0001127602-21-019792","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/882796/000112760221019792/form4.xml","form_type":"4"}},{"id":2670894,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":78483,"kind":"person","name":"Hutson Nancy J","position":1,"cik":"0001379222","reported_name":"Hutson Nancy J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-06-14T20:29:33.000Z","date":"2021-06-10","kind":"sale","acquired":false,"shares":23333,"price":16.86,"value":393394.38,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 10, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price in column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $16.76 to $17.00. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote."}],"balance_after":65073,"source":{"system":"sec-edgar","filing":"0001127602-21-019792","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882796/000112760221019792/form4.xml","form_type":"4"}},{"id":2670893,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":78483,"kind":"person","name":"Hutson Nancy J","position":1,"cik":"0001379222","reported_name":"Hutson Nancy J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-06-14T20:29:33.000Z","date":"2021-06-10","kind":"exercise","acquired":true,"shares":15000,"price":3.32,"value":49800.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 10, 2021."}],"balance_after":88406,"source":{"system":"sec-edgar","filing":"0001127602-21-019792","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882796/000112760221019792/form4.xml","form_type":"4"}},{"id":2670892,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":78483,"kind":"person","name":"Hutson Nancy J","position":1,"cik":"0001379222","reported_name":"Hutson Nancy J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-06-14T20:29:33.000Z","date":"2021-06-10","kind":"exercise","acquired":true,"shares":8333,"price":2.85,"value":23749.05,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 10, 2021."}],"balance_after":73406,"source":{"system":"sec-edgar","filing":"0001127602-21-019792","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882796/000112760221019792/form4.xml","form_type":"4"}},{"id":2671440,"issuer":{"id":82875,"kind":"organization","name":"Clearside Biomedical, Inc.","symbol":"CLSD"},"owners":[{"id":78483,"kind":"person","name":"Hutson Nancy J","position":1,"cik":"0001379222","reported_name":"Hutson Nancy J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-11T17:40:44.000Z","date":"2021-06-10","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest in full on the earlier of the Issuer's next annual meeting of stockholders or June 10, 2022."}],"balance_after":25000,"derivative":{"exercise_price":3.11,"expiration_date":"2031-06-09","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-21-039959","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1379222/000120919121039959/doc4.xml","form_type":"4"}},{"id":2681304,"issuer":{"id":113305,"kind":"organization","name":"PhaseBio Pharmaceuticals Inc","symbol":"PHAS"},"owners":[{"id":78483,"kind":"person","name":"Hutson Nancy J","position":1,"cik":"0001379222","reported_name":"Hutson Nancy J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-employee Director Stock Option (right to buy)","published_at":"2021-06-04T18:05:23.000Z","date":"2021-06-03","kind":"grant","acquired":true,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest upon the earlier of the one year anniversary of the grant date or the 2022 annual meeting, subject to the reporting person's continuous service through each such date"}],"balance_after":14000,"derivative":{"exercise_price":3.53,"expiration_date":"2031-06-03","underlying":"Common Stock","underlying_shares":14000},"source":{"system":"sec-edgar","filing":"0001169245-21-000060","document":"wf-form4_162284430349995.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1169245/000116924521000060/wf-form4_162284430349995.xml","form_type":"4"}},{"id":2690012,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":78483,"kind":"person","name":"Hutson Nancy J","position":1,"cik":"0001379222","reported_name":"Hutson Nancy J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-06-01T20:24:09.000Z","date":"2021-05-28","kind":"grant","acquired":true,"shares":317,"price":15.77,"value":4999.09,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Shares of Common Stock issued to the reporting person in lieu of 50% of the quarterly cash Board Member retainer of $10,000."}],"balance_after":65073,"source":{"system":"sec-edgar","filing":"0001127602-21-018492","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882796/000112760221018492/form4.xml","form_type":"4"}},{"id":2694227,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":78483,"kind":"person","name":"Hutson Nancy J","position":1,"cik":"0001379222","reported_name":"Hutson Nancy J","relationship":{"director":true}}],"security":"Automatic Stock Option Grant","published_at":"2021-05-27T20:24:12.000Z","date":"2021-05-25","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Automatic non-employee director grant pursuant to the BioCryst Pharmaceuticals, Inc. Stock Incentive Plan."}],"balance_after":40000,"derivative":{"exercise_price":13.28,"exercise_date":"2022-05-25","expiration_date":"2031-05-25","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001127602-21-018179","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882796/000112760221018179/form4.xml","form_type":"4"}},{"id":2788858,"issuer":{"id":82875,"kind":"organization","name":"Clearside Biomedical, Inc.","symbol":"CLSD"},"owners":[{"id":78483,"kind":"person","name":"Hutson Nancy J","position":1,"cik":"0001379222","reported_name":"Hutson Nancy J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-15T16:50:39.000Z","date":"2021-03-12","kind":"purchase","acquired":true,"shares":5000,"price":3.105,"value":15525.0,"ownership":{"direct":true},"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001209191-21-020488","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1379222/000120919121020488/doc4.xml","form_type":"4"}},{"id":2823014,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":78483,"kind":"person","name":"Hutson Nancy J","position":1,"cik":"0001379222","reported_name":"Hutson Nancy J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-03-02T21:53:50.000Z","date":"2021-02-26","kind":"grant","acquired":true,"shares":463,"price":10.78,"value":4991.14,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Shares of Common Stock issued to the reporting person in lieu of 50% of the quarterly cash Board Member retainer of $10,000."}],"balance_after":64756,"source":{"system":"sec-edgar","filing":"0001127602-21-008761","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882796/000112760221008761/form4.xml","form_type":"4"}},{"id":2961778,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":78483,"kind":"person","name":"Hutson Nancy J","position":1,"cik":"0001379222","reported_name":"Hutson Nancy J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2020-12-02T21:16:41.000Z","date":"2020-11-30","kind":"grant","acquired":true,"shares":978,"price":5.11,"value":4997.58,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Shares of Common Stock issued to the reporting person in lieu of 50% of the quarterly cash Board Member retainer of $10,000."}],"balance_after":64293,"source":{"system":"sec-edgar","filing":"0001127602-20-030287","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882796/000112760220030287/form4.xml","form_type":"4"}},{"id":3041867,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":78483,"kind":"person","name":"Hutson Nancy J","position":1,"cik":"0001379222","reported_name":"Hutson Nancy J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2020-09-02T20:44:11.000Z","date":"2020-08-31","kind":"grant","acquired":true,"shares":1204,"price":4.15,"value":4996.6,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Shares of Common Stock issued to the reporting person in lieu of 50% of the quarterly cash Board Member retainer of $10,000."}],"balance_after":63315,"source":{"system":"sec-edgar","filing":"0001127602-20-024646","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882796/000112760220024646/form4.xml","form_type":"4"}},{"id":3104037,"issuer":{"id":82875,"kind":"organization","name":"Clearside Biomedical, Inc.","symbol":"CLSD"},"owners":[{"id":78483,"kind":"person","name":"Hutson Nancy J","position":1,"cik":"0001379222","reported_name":"Hutson Nancy J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-06-19T16:35:08.000Z","date":"2020-06-18","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest in full on the earlier of the Issuer's next annual meeting of stockholders or June 18, 2021."}],"balance_after":25000,"derivative":{"exercise_price":2,"expiration_date":"2030-06-17","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-20-037942","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1379222/000120919120037942/doc4.xml","form_type":"4"}},{"id":3108549,"issuer":{"id":124463,"kind":"organization","name":"Endo International plc","symbol":"ENDP"},"owners":[{"id":78483,"kind":"person","name":"Hutson Nancy J","position":1,"cik":"0001379222","reported_name":"Hutson Nancy J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2020-06-16T16:06:35.000Z","date":"2020-06-12","kind":"tax_withholding","acquired":false,"shares":12245,"price":3.43,"value":42000.35,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These shares represent ordinary shares withheld by Endo International plc to satisfy Dr. Hutson's tax withholding obligations on shares acquired on June 12, 2020."}],"balance_after":91219,"source":{"system":"sec-edgar","filing":"0001593034-20-000050","document":"wf-form4_159233797361893.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1379222/000159303420000050/wf-form4_159233797361893.xml","form_type":"4"}},{"id":3108548,"issuer":{"id":124463,"kind":"organization","name":"Endo International plc","symbol":"ENDP"},"owners":[{"id":78483,"kind":"person","name":"Hutson Nancy J","position":1,"cik":"0001379222","reported_name":"Hutson Nancy J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2020-06-16T16:06:35.000Z","date":"2020-06-12","kind":"grant","acquired":true,"shares":25511,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These ordinary shares were granted to Dr. Hutson on June 12, 2020 in consideration of her services on Endo International plc's Board of Directors."}],"balance_after":103464,"source":{"system":"sec-edgar","filing":"0001593034-20-000050","document":"wf-form4_159233797361893.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1379222/000159303420000050/wf-form4_159233797361893.xml","form_type":"4"}},{"id":3120777,"issuer":{"id":113305,"kind":"organization","name":"PhaseBio Pharmaceuticals Inc","symbol":"PHAS"},"owners":[{"id":78483,"kind":"person","name":"Hutson Nancy J","position":1,"cik":"0001379222","reported_name":"Hutson Nancy J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-employee Director Stock Option (right to buy)","published_at":"2020-06-05T18:57:21.000Z","date":"2020-06-03","kind":"grant","acquired":true,"shares":16000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest upon the earlier of the one year anniversary of the grant date or the 2021 annual meeting, subject to the reporting person's continuous service through each such date"}],"balance_after":16000,"derivative":{"exercise_price":4.86,"expiration_date":"2030-06-03","underlying":"Common Stock","underlying_shares":16000},"source":{"system":"sec-edgar","filing":"0001169245-20-000063","document":"wf-form4_159139782229645.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000063/wf-form4_159139782229645.xml","form_type":"4"}},{"id":3125454,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":78483,"kind":"person","name":"Hutson Nancy J","position":1,"cik":"0001379222","reported_name":"Hutson Nancy J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2020-06-03T20:20:07.000Z","date":"2020-06-01","kind":"grant","acquired":true,"shares":2224,"price":4.495,"value":9996.88,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Shares of Common Stock issued to the reporting person in lieu of quarterly cash Board Member retainer of $10,000"}],"balance_after":62111,"source":{"system":"sec-edgar","filing":"0001127602-20-018711","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882796/000112760220018711/form4.xml","form_type":"4"}},{"id":3138759,"issuer":{"id":82875,"kind":"organization","name":"Clearside Biomedical, Inc.","symbol":"CLSD"},"owners":[{"id":78483,"kind":"person","name":"Hutson Nancy J","position":1,"cik":"0001379222","reported_name":"Hutson Nancy J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-21T16:50:44.000Z","date":"2020-05-20","kind":"purchase","acquired":true,"shares":5000,"price":1.85,"value":9250.0,"ownership":{"direct":true},"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001209191-20-031325","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1379222/000120919120031325/doc4.xml","form_type":"4"}},{"id":3149737,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":78483,"kind":"person","name":"Hutson Nancy J","position":1,"cik":"0001379222","reported_name":"Hutson Nancy J","relationship":{"director":true}}],"security":"Automatic Stock Option Grant","published_at":"2020-05-14T20:25:11.000Z","date":"2020-05-12","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Automatic non-employee director grant pursuant to the BioCryst Pharmaceuticals, Inc. Stock Incentive Plan."}],"balance_after":40000,"derivative":{"exercise_price":5.41,"exercise_date":"2021-05-12","expiration_date":"2030-05-12","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001127602-20-016569","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882796/000112760220016569/form4.xml","form_type":"4"}},{"id":3170943,"issuer":{"id":82875,"kind":"organization","name":"Clearside Biomedical, Inc.","symbol":"CLSD"},"owners":[{"id":78483,"kind":"person","name":"Hutson Nancy J","position":1,"cik":"0001379222","reported_name":"Hutson Nancy J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-04-23T16:58:57.000Z","date":"2020-04-21","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest and become exercisable in 36 equal monthly installments, subject to the Reporting Person's continuous service as of such vesting dates."}],"balance_after":30000,"derivative":{"exercise_price":2.09,"expiration_date":"2030-04-20","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001209191-20-025448","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1379222/000120919120025448/doc4.xml","form_type":"4"}},{"id":3235270,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":78483,"kind":"person","name":"Hutson Nancy J","position":1,"cik":"0001379222","reported_name":"Hutson Nancy J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2020-03-03T21:50:11.000Z","date":"2020-03-01","kind":"grant","acquired":true,"shares":3333,"price":3,"value":9999.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Shares of Common Stock issued to the reporting person in lieu of quarterly cash Board Member retainer of $10,000"}],"balance_after":59887,"source":{"system":"sec-edgar","filing":"0001127602-20-009065","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882796/000112760220009065/form4.xml","form_type":"4"}},{"id":3355086,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":78483,"kind":"person","name":"Hutson Nancy J","position":1,"cik":"0001379222","reported_name":"Hutson Nancy J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-12-03T22:12:07.000Z","date":"2019-12-01","kind":"grant","acquired":true,"shares":3508,"price":2.85,"value":9997.8,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Shares of Common Stock issued to the reporting person in lieu of quarterly cash Board Member retainer of $10,000."}],"balance_after":56554,"source":{"system":"sec-edgar","filing":"0001127602-19-034165","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882796/000112760219034165/form4.xml","form_type":"4"}},{"id":3369157,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":78483,"kind":"person","name":"Hutson Nancy J","position":1,"cik":"0001379222","reported_name":"Hutson Nancy J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-11-18T21:10:07.000Z","date":"2019-11-18","kind":"purchase","acquired":true,"shares":10000,"price":1.45,"value":14500.0,"ownership":{"direct":true},"balance_after":53046,"source":{"system":"sec-edgar","filing":"0001127602-19-033022","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882796/000112760219033022/form4.xml","form_type":"4"}},{"id":3423969,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":78483,"kind":"person","name":"Hutson Nancy J","position":1,"cik":"0001379222","reported_name":"Hutson Nancy J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-09-04T20:12:10.000Z","date":"2019-09-01","kind":"grant","acquired":true,"shares":3344,"price":2.99,"value":9998.56,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Shares of Common Stock issued to the reporting person in lieu of quarterly cash Board Member retainer of $10,000."}],"balance_after":43046,"source":{"system":"sec-edgar","filing":"0001127602-19-027862","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882796/000112760219027862/form4.xml","form_type":"4"}},{"id":3489271,"issuer":{"id":124463,"kind":"organization","name":"Endo International plc","symbol":"ENDP"},"owners":[{"id":78483,"kind":"person","name":"Hutson Nancy J","position":1,"cik":"0001379222","reported_name":"Hutson Nancy J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2019-06-14T19:30:24.000Z","date":"2019-06-12","kind":"tax_withholding","acquired":false,"shares":25829,"price":4.46,"value":115197.34,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These shares represent ordinary shares withheld by Endo International plc to satisfy Dr. Hutson's tax withholding obligations on shares acquired on June 12, 2019."}],"balance_after":77953,"source":{"system":"sec-edgar","filing":"0001209191-19-037300","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1379222/000120919119037300/doc4.xml","form_type":"4"}},{"id":3489270,"issuer":{"id":124463,"kind":"organization","name":"Endo International plc","symbol":"ENDP"},"owners":[{"id":78483,"kind":"person","name":"Hutson Nancy J","position":1,"cik":"0001379222","reported_name":"Hutson Nancy J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2019-06-14T19:30:24.000Z","date":"2019-06-12","kind":"grant","acquired":true,"shares":53812,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These ordinary shares were granted to Dr. Hutson on June 12, 2019 in consideration of her services on Endo International plc's Board of Directors."}],"balance_after":103782,"source":{"system":"sec-edgar","filing":"0001209191-19-037300","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1379222/000120919119037300/doc4.xml","form_type":"4"}},{"id":3506757,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":78483,"kind":"person","name":"Hutson Nancy J","position":1,"cik":"0001379222","reported_name":"Hutson Nancy J","relationship":{"director":true}}],"security":"Automatic Stock Option Grant","published_at":"2019-05-31T20:19:12.000Z","date":"2019-05-29","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Automatic non-employee director grant pursuant to the BioCryst Pharmaceuticals, Inc. Stock Incentive Plan."}],"balance_after":30000,"derivative":{"exercise_price":2.91,"exercise_date":"2020-05-29","expiration_date":"2029-05-29","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001127602-19-020310","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882796/000112760219020310/form4.xml","form_type":"4"}},{"id":3530103,"issuer":{"id":113305,"kind":"organization","name":"PhaseBio Pharmaceuticals Inc","symbol":"PHAS"},"owners":[{"id":78483,"kind":"person","name":"Hutson Nancy J","position":1,"cik":"0001379222","reported_name":"Hutson Nancy J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-employee Director Stock Option (right to buy)","published_at":"2019-05-13T16:36:12.000Z","date":"2019-05-09","kind":"grant","acquired":true,"shares":11000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest upon the earlier of the one year anniversary of the grant date or the date of the 2020 annual meeting, subject to the reporting person's continuous service through each such date"}],"balance_after":11000,"derivative":{"exercise_price":13.23,"expiration_date":"2029-05-09","underlying":"Common Stock","underlying_shares":11000},"source":{"system":"sec-edgar","filing":"0001209191-19-029352","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1169245/000120919119029352/doc4.xml","form_type":"4"}},{"id":3623598,"issuer":{"id":113305,"kind":"organization","name":"PhaseBio Pharmaceuticals Inc","symbol":"PHAS"},"owners":[{"id":78483,"kind":"person","name":"Hutson Nancy J","position":1,"cik":"0001379222","reported_name":"Hutson Nancy J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to buy)","published_at":"2019-03-01T16:47:09.000Z","date":"2019-02-27","kind":"grant","acquired":true,"shares":8900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest in equal monthly installments over 36 months from October 17, 2018, subject to the reporting person's continued service through each such date."}],"balance_after":8900,"derivative":{"exercise_price":3.15,"expiration_date":"2029-02-27","underlying":"Common Stock","underlying_shares":8900},"source":{"system":"sec-edgar","filing":"0001209191-19-015032","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1169245/000120919119015032/doc4.xml","form_type":"4"}},{"id":3729615,"issuer":{"id":113305,"kind":"organization","name":"PhaseBio Pharmaceuticals Inc","symbol":"PHAS"},"owners":[{"id":78483,"kind":"person","name":"Hutson Nancy J","position":1,"cik":"0001379222","reported_name":"Hutson Nancy J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-12-17T16:19:14.000Z","date":"2018-12-17","kind":"purchase","acquired":true,"shares":1000,"price":4.46,"value":4460.0,"ownership":{"direct":false,"nature":"Held in an individual retirement account for the benefit of the reporting person"},"balance_after":1000,"source":{"system":"sec-edgar","filing":"0001209191-18-062934","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1169245/000120919118062934/doc4.xml","form_type":"4"}},{"id":3760632,"issuer":{"id":124463,"kind":"organization","name":"Endo International plc","symbol":"ENDP"},"owners":[{"id":78483,"kind":"person","name":"Hutson Nancy J","position":1,"cik":"0001379222","reported_name":"Hutson Nancy J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2018-11-16T16:03:21.000Z","date":"2018-11-15","kind":"sale","acquired":false,"shares":10000,"price":12.83,"value":128300.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These sales of ordinary shares were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended."}],"balance_after":49970,"source":{"system":"sec-edgar","filing":"0001209191-18-058924","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1379222/000120919118058924/doc4.xml","form_type":"4"}},{"id":3885604,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":78483,"kind":"person","name":"Hutson Nancy J","position":1,"cik":"0001379222","reported_name":"Hutson Nancy J","relationship":{"director":true}}],"security":"Automatic Stock Option Grant","published_at":"2018-06-22T13:35:17.000Z","date":"2018-06-20","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Automatic non-employee director grant pursuant to the BioCryst Pharmaceuticals, Inc. Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Vests 1/12th per month over twelve months beginning July 20, 2018."}],"balance_after":30000,"derivative":{"exercise_price":6.09,"exercise_date":"2018-07-20","expiration_date":"2028-06-20","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001127602-18-021730","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882796/000112760218021730/form4.xml","form_type":"4"}},{"id":3896489,"issuer":{"id":124463,"kind":"organization","name":"Endo International plc","symbol":"ENDP"},"owners":[{"id":78483,"kind":"person","name":"Hutson Nancy J","position":1,"cik":"0001379222","reported_name":"Hutson Nancy J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2018-06-12T16:09:10.000Z","date":"2018-06-08","kind":"tax_withholding","acquired":false,"shares":15019,"price":7.67,"value":115195.73,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These shares represent ordinary shares withheld by Endo International plc to satisfy Dr. Hutson's tax withholding obligations on shares acquired on June 8, 2018."}],"balance_after":59970,"source":{"system":"sec-edgar","filing":"0001209191-18-037210","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1379222/000120919118037210/doc4.xml","form_type":"4"}},{"id":3896488,"issuer":{"id":124463,"kind":"organization","name":"Endo International plc","symbol":"ENDP"},"owners":[{"id":78483,"kind":"person","name":"Hutson Nancy J","position":1,"cik":"0001379222","reported_name":"Hutson Nancy J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2018-06-12T16:09:10.000Z","date":"2018-06-08","kind":"grant","acquired":true,"shares":31291,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These ordinary shares were granted to Dr. Hutson on June 8, 2018 in consideration of her services on Endo International plc's Board of Directors."}],"balance_after":74989,"source":{"system":"sec-edgar","filing":"0001209191-18-037210","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1379222/000120919118037210/doc4.xml","form_type":"4"}},{"id":3909475,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":78483,"kind":"person","name":"Hutson Nancy J","position":1,"cik":"0001379222","reported_name":"Hutson Nancy J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2018-06-04T18:48:46.000Z","date":"2018-06-01","kind":"grant","acquired":true,"shares":1555,"price":6.43,"value":9998.65,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Shares of Common Stock issued to the reporting person in lieu of quarterly cash Board Member retainer of $10,000."}],"balance_after":39702,"source":{"system":"sec-edgar","filing":"0001127602-18-019686","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882796/000112760218019686/form4.xml","form_type":"4"}},{"id":4021924,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":78483,"kind":"person","name":"Hutson Nancy J","position":1,"cik":"0001379222","reported_name":"Hutson Nancy J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2018-03-02T19:11:48.000Z","date":"2018-03-01","kind":"grant","acquired":true,"shares":2012,"price":4.97,"value":9999.64,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Shares of Common Stock issued to the reporting person in lieu of quarterly cash Board Member retainer of $10,000."}],"balance_after":38147,"source":{"system":"sec-edgar","filing":"0001127602-18-009560","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882796/000112760218009560/form4.xml","form_type":"4"}},{"id":4145102,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":78483,"kind":"person","name":"Hutson Nancy J","position":1,"cik":"0001379222","reported_name":"Hutson Nancy J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2017-12-04T20:50:46.000Z","date":"2017-12-01","kind":"grant","acquired":true,"shares":1968,"price":5.08,"value":9997.44,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Shares of Common Stock issued to the reporting person in lieu of quarterly cash Board Member retainer of $10,000."}],"balance_after":36135,"source":{"system":"sec-edgar","filing":"0001127602-17-033780","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882796/000112760217033780/form4.xml","form_type":"4"}},{"id":4218732,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":78483,"kind":"person","name":"Hutson Nancy J","position":1,"cik":"0001379222","reported_name":"Hutson Nancy J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2017-09-05T15:27:28.000Z","date":"2017-09-01","kind":"grant","acquired":true,"shares":1960,"price":5.1,"value":9996.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Shares of Common Stock issued to the reporting person in lieu of quarterly cash Board Member retainer of $10,000."}],"balance_after":34167,"source":{"system":"sec-edgar","filing":"0001127602-17-026878","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882796/000112760217026878/form4.xml","form_type":"4"}},{"id":4285155,"issuer":{"id":124463,"kind":"organization","name":"Endo International plc","symbol":"ENDP"},"owners":[{"id":78483,"kind":"person","name":"Hutson Nancy J","position":1,"cik":"0001379222","reported_name":"Hutson Nancy J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2017-06-12T21:38:51.000Z","date":"2017-06-09","kind":"tax_withholding","acquired":false,"shares":11488,"price":11.49,"value":131997.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"These shares represent ordinary shares withheld by Endo International plc to satisfy Dr. Hutson's tax withholding obligations on shares acquired."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number represents ordinary shares, of which 6,515 have been deferred under Endo International plc's directors deferred compensation plan."}],"balance_after":43698,"source":{"system":"sec-edgar","filing":"0001209191-17-039328","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1379222/000120919117039328/doc4.xml","form_type":"4"}},{"id":4285154,"issuer":{"id":124463,"kind":"organization","name":"Endo International plc","symbol":"ENDP"},"owners":[{"id":78483,"kind":"person","name":"Hutson Nancy J","position":1,"cik":"0001379222","reported_name":"Hutson Nancy J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2017-06-12T21:38:51.000Z","date":"2017-06-09","kind":"grant","acquired":true,"shares":23934,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These ordinary shares were granted to Dr. Hutson on June 9, 2017 in consideration of her services on Endo International plc's Board of Directors."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number represents ordinary shares, of which 6,515 have been deferred under Endo International plc's directors deferred compensation plan."}],"balance_after":55186,"source":{"system":"sec-edgar","filing":"0001209191-17-039328","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1379222/000120919117039328/doc4.xml","form_type":"4"}},{"id":4296877,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":78483,"kind":"person","name":"Hutson Nancy J","position":1,"cik":"0001379222","reported_name":"Hutson Nancy J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2017-06-02T20:01:58.000Z","date":"2017-06-01","kind":"grant","acquired":true,"shares":1941,"price":5.15,"value":9996.15,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Shares of Common Stock issued to the reporting person in lieu of quarterly cash Board Member retainer of $10,000."}],"balance_after":32207,"source":{"system":"sec-edgar","filing":"0001127602-17-020296","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882796/000112760217020296/form4.xml","form_type":"4"}},{"id":4305570,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":78483,"kind":"person","name":"Hutson Nancy J","position":1,"cik":"0001379222","reported_name":"Hutson Nancy J","relationship":{"director":true}}],"security":"Automatic Stock Option Grant","published_at":"2017-05-25T15:45:02.000Z","date":"2017-05-24","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Automatic non-employee director grant pursuant to the BioCryst Pharmaceuticals, Inc. Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Vests 1/12th per month over twelve months beginning June 24, 2017."}],"balance_after":30000,"derivative":{"exercise_price":5.13,"exercise_date":"2017-06-24","expiration_date":"2027-05-24","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001127602-17-019331","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882796/000112760217019331/form4.xml","form_type":"4"}},{"id":4390438,"issuer":{"id":124463,"kind":"organization","name":"Endo International plc","symbol":"ENDP"},"owners":[{"id":78483,"kind":"person","name":"Hutson Nancy J","position":1,"cik":"0001379222","reported_name":"Hutson Nancy J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2017-03-10T10:24:24.000Z","date":"2017-03-09","kind":"sale","acquired":false,"shares":5325,"price":10.82,"value":57616.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These sales of ordinary shares were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number represents ordinary shares, of which 6,515 have been deferred under Endo International plc's directors deferred compensation plan."}],"balance_after":31252,"source":{"system":"sec-edgar","filing":"0001209191-17-019749","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1379222/000120919117019749/doc4.xml","form_type":"4"}},{"id":4411569,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":78483,"kind":"person","name":"Hutson Nancy J","position":1,"cik":"0001379222","reported_name":"Hutson Nancy J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2017-03-02T20:05:37.000Z","date":"2017-03-01","kind":"grant","acquired":true,"shares":1602,"price":6.24,"value":9996.48,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Shares of Common Stock issued to the reporting person in lieu of quarterly cash Board Member retainer of $10,000."}],"balance_after":30266,"source":{"system":"sec-edgar","filing":"0001127602-17-009568","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882796/000112760217009568/form4.xml","form_type":"4"}},{"id":4536040,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":78483,"kind":"person","name":"Hutson Nancy J","position":1,"cik":"0001379222","reported_name":"Hutson Nancy J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2016-12-02T19:06:32.000Z","date":"2016-12-01","kind":"grant","acquired":true,"shares":1788,"price":5.59,"value":9994.92,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Shares of Common Stock issued to the reporting person in lieu of quarterly cash Board Member retainer of $10,000."}],"balance_after":28664,"source":{"system":"sec-edgar","filing":"0001127602-16-068908","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882796/000112760216068908/form4.xml","form_type":"4"}},{"id":4612028,"issuer":{"id":315,"kind":"organization","name":"BIOCRYST PHARMACEUTICALS INC","symbol":"BCRX"},"owners":[{"id":78483,"kind":"person","name":"Hutson Nancy J","position":1,"cik":"0001379222","reported_name":"Hutson Nancy J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2016-09-06T19:25:47.000Z","date":"2016-09-01","kind":"grant","acquired":true,"shares":2433,"price":4.11,"value":9999.63,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Shares of Common Stock issued to the reporting person in lieu of quarterly cash Board Member retainer of $10,000."}],"balance_after":26876,"source":{"system":"sec-edgar","filing":"0001127602-16-061903","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882796/000112760216061903/form4.xml","form_type":"4"}}]}